Global MicroRNA Market: Research Tools, Diagnostics & Therapeutics Reviewed in New Market Research Report at

Share Article

“MicroRNA Research Tools, Diagnostics and Therapeutics: Global Markets” report provides an overview of the global market for microRNA diagnostics and therapeutics, with an analysis of the commercial potential of this research field along with global market trends and data from 2011, estimates for 2012, as well as projections of compound annual growth rates (CAGRs) through 2017.

Although microRNAs are part of the RNA research market in general, the microRNA sector exhibits specific characteristics and differences in its market participants and competitive landscape.

This report provides an examination of the extensive portfolio of miRNA pathway drug candidates, some already in Phase II clinical trials, showing promising clinical data in different areas of medicine, such as cancer, HCV infection, and cardiovascular diseases. A focus on recent drug candidates, products, deals between different pharmaceutical companies, major participants, and new trends and developments during the last two years as well as forecasts of the future situation and major drawbacks of the miRNA drug development model and possible solutions for these obstacles, especially in context of drug stability and delivery, are covered. Additionally, identification of the main markets for RNA therapeutics and comprehensive company profiles of major players in the industry are also included in this report.


This report is a business tool that can help market players properly evaluate new commercial opportunities in the microRNA market covering reagent, diagnostic and therapeutic submarkets. The geographic scope of this study is global. This market is generally complex and consists of a number of different segments, each of which is affected differently by scientific and technological developments. This report identifies the main factors affecting each segment, and forecasts market growth, future trends, and product development in every major segment of this market.


Both primary and secondary research methodologies were used in preparing this study. Initially, a comprehensive and exhaustive search of the literature on drug discovery and already marketed products was conducted. These secondary sources included drug discovery and science–related journals, textbooks, press releases, marketing literature, other product/promotional literature, annual reports, security analyst reports, and other publications. A patent search and analysis were also conducted.

In a second phase, a series of semi–structured interviews was conducted with company representatives, bench scientists, marketing representatives, and other personnel at biotechnology and pharmaceutical companies. Other sources included academics, technology, and consulting companies. Subsequent analysis of the documents and interview notes was iterative.


This report is intended for business development professionals, entrepreneurs, and other investors who need to fully understand and properly evaluate each segment in the market for microRNA research tools, diagnostics and therapeutics. It provides insights into the market position of major companies, and shows new opportunities otherwise overlooked or less known to the business community.

Buy your copy of this report @

List Of Companies Mentioned In Report Include:

Access Pharmaceuticals
Aegera Therapeutics
Agilent Technologies
Alnylam Pharmaceuticals
Antisense Pharma Gmbh
Aparna Biosciences Corp.
Applied Biological Materials Inc.
Astrazeneca Pharmaceuticals Lp
Asuragen Inc.
Avi Biopharma/Sarepta Therapeutics
Benitec Biopharma
Biocancell Therapeutics Inc.
Biogen Idec
Calando Pharmaceuticals Inc.
Cbc Comprehensive Biomarker Center Gmbh
Cenix Bioscience Gmbh
Clontech Laboratories
Covance Inc.
Dicerna Pharmaceuticals Inc.
Egen Inc.
Eli Lilly And Co.
Enzo Biochem
Enzon Pharmaceuticals Inc.
Exiqon A/S
F. Hoffman-La Roche Ag
Genecopoeia Inc.
Genosensor Corp.
Gensignia Inc.
Genta Inc.
Groove Biopharma
Gsk U.S.
Htg Molecular Diagnostics Inc.
Ico Therapeutics Inc.
Idera Pharmaceuticals
Illumina Inc.
Interna Technologies B.V.
Isis Pharmaceuticals
Lc Sciences
Life Technologies Corp.
Lorus Therapeutics Inc.
Marina Biotech
Miragen Therapeutics
Mirna Therapeutics
Nanostring Technologies
Norgen Biotek
Novartis International Ag
Opko Health Inc.
Phalanx Biotech Group
Prolias Technologies
Quark Pharmaceuticals Inc.
Regulus Therapeutics
Rosetta Genomics
Rxi Pharmaceuticals Corp.
Sanofi U.S.
Santaris Pharma A/S
Senesco Technologies Inc.
Silence Therapeutics
Sirnaomics Inc.
Tacere Therapeutics Inc.
Tekmira Pharmaceuticals Corp.
Thermo Fisher Scientific Inc.
Traversa Therapeutics Inc.
Wafergen Biosystems Inc.

Explore more reports on the Biotechnology Market @

Contact sales(at)reportsnreports(dot)com for further information.

About Us: ( is an online market research reports library of 200,000+ in-depth studies of over 5000 micro markets.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Follow us on
Visit website